Manufacturer record

Biomax Biotechnics (P) Ltd. 261: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Biomax Biotechnics (P) Ltd. 261 (Haryana) were declared Not of Standard Quality between February 2020 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

5 records linked to Biomax Biotechnics (P) Ltd. 261 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2020 to Apr 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2020
2
Products affected
Dissolution
Most common failure
Apr 2025
Latest alert

Flagged batches per year

2020 · 42025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Telmisartan & Amlodipine Tablets IP (XTEL-AM) BBT240427AMfg 2024-05 · Exp 2026-04 The sample does not conform to the claim as per IP 2022 in respect to Dissolution Test of AmlodipineDissolution DTL BaddiState lab Apr 2025
Albendazole Tablets I.P. 400 mg BBT19327AMfg 2019-08 · Exp 2021-07 DissolutionDissolution RDTL GuwahatiState lab Mar 2020
Albendazole 400mg. Tablets I.P. BBT19329AMfg 2019-08 · Exp 2021-07 DissolutionDissolution RDTL GuwahatiState lab Feb 2020
Albendazole 400 mg. Tablets I.P. BBT19326AMfg 2019-08 · Exp 2021-07 DissolutionDissolution RDTL GuwahatiState lab Feb 2020
Albendazole 400 mg. Tablets I.P. BBT19331AMfg 2019-08 · Exp 2021-07 DissolutionDissolution RDTL GuwahatiState lab Feb 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.